A new European Union (EU) funded research project called ‘euHeart,’ aimed at improving the diagnosis, therapy planning and treatment of cardiovascular disease will be led by Netherlands-based Royal Philips Electronics, says the company.
The EuHeart consortium comprises public and private partners from 16 research, academic, industrial and medical organizations from six different European countries. It will run for four years and has a budget of approximately EUR 19 million, of which about EUR 14 million will be provided by the European Union.
The euHeart consortium aims to develop advanced computer models of the human heart that can be personalized to patient-specific conditions using clinical data from various sources, such as CT and MRI scans, measurements of blood flow and blood pressure in the coronary arteries and ECGs, according to the company.
